The 2001 UK foot and mouth disease epidemic was a human tragedy, not just an animal one, concludes a study published by the British Medical Journal. The UKs foot and mouth disease epidemic in 2001 has been described as the most serious event ever to occur in a country previously free of the disease. Between 6.5 million and 10 million animals were slaughtered across the UK and the disaster caused widespread disruption and closure of much of the British countryside for more than a year. But because the epidemic was treated as an animal problem, little is known about the human cost of the disaster.
Researchers from Lancaster University Institute for Health Research recruited a panel of 54 individuals, representing a wide range of rural workers and residents. Over a period of 18 months, panel members wrote more than 3,000 weekly diaries which were analyzed along with in-depth interviews and participated in group discussions to capture evidence about the impact of the disaster and processes of recovery.
Their reports showed that life after the foot and mouth epidemic was accompanied by distress, feelings of bereavement, fear of a new disaster, loss of trust in authority and a sense that the value of local knowledge had been undermined.
Distress was experienced well beyond the farming community. In the aftermath of the disaster, health and social problems included flashbacks, nightmares, uncontrollable emotion, conflict within communities and increased social isolation. In the longer term, there was evidence of stress, anxieties about emissions from disposal sites, loss of confidence in authority, confusion, bitterness and increased fear of unemployment. Many of these effects continued to feature in the diaries throughout the 18 month period.
But the team also found that suffering was alleviated by trusted informal and formal support networks. This implies that statutory and voluntary organizations have a more complex and enduring role after a disaster than has been understood.
They argue for more flexibility in disaster planning, rather than the creation of new bodies or more targets and protocols. People who have experienced a disaster may not be sick as a result, but they need careful and appropriate support to rebuild their lives and regain confidence, they say.
They recommend joint service reviews of what counts as a disaster, regular sharing of intelligence, debriefing and peer support for front line workers, increased community involvement in disaster management, and wider more flexible access to regeneration funding and rural health outreach work.
Source: British Medical Journal
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.